Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.
暂无分享,去创建一个
R. Hintzen | J. Laman | S. Amor | E. Nieuwenhuis | Jon D Laman | R. Boot | J. Aerts | Rogier Q Hintzen | Leonie A Boven | Sandra Amor | M. van Zwam | Marjan Van Meurs | Marloes Van Zwam | Annet Wierenga-Wolf | Rolf G Boot | Johannes M Aerts | Edward E Nieuwenhuis | A. Wierenga-wolf | L. Boven | M. van Meurs
[1] G. Denning,et al. Pulmonary Surfactant Protein A Activates a Phosphatidylinositol 3-Kinase/Calcium Signal Transduction Pathway in Human Macrophages: Participation in the Up-Regulation of Mannose Receptor Activity1 , 2005, The Journal of Immunology.
[2] B. Becher,et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis (vol 11, pg 146, 2005) , 2005 .
[3] C. Matute,et al. Multiple sclerosis: novel perspectives on newly forming lesions , 2005, Trends in Neurosciences.
[4] L. Steinman,et al. Multiple sclerosis: trapped in deadly glue , 2005, Nature Medicine.
[5] S. Miller,et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.
[6] B. Becher,et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.
[7] B. Becher,et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.
[8] Siamon Gordon,et al. Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400011-JLR200 , 2005, Journal of Lipid Research.
[9] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[10] Peter Tontonoz,et al. LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response , 2004, Cell.
[11] L. Boon,et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. , 2004, American journal of clinical pathology.
[12] Hans Lassmann,et al. Recent neuropathological findings in MS—implications for diagnosis and therapy , 2004, Journal of Neurology.
[13] Ioannis Milonas,et al. Axonal damage in multiple sclerosis: a complex issue in a complex disease , 2004, Clinical Neurology and Neurosurgery.
[14] F. Brombacher,et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. , 2004, Immunity.
[15] C. Raine,et al. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation , 2004, Annals of neurology.
[16] B. Becher,et al. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. , 2003, The Journal of clinical investigation.
[17] A. Mantovani,et al. Unique Regulation of CCL18 Production by Maturing Dendritic Cells1 , 2003, The Journal of Immunology.
[18] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[19] L. van der Fits,et al. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor‐2 (IRF‐2) , 2003, The Journal of pathology.
[20] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[21] Peter Tontonoz,et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.
[22] Y. Hannun,et al. Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.
[23] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[24] M. Stollenwerk,et al. Decreased inducibility of TNF expression in lipid-loaded macrophages , 2002, BMC Immunology.
[25] T. Lawrence,et al. Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.
[26] Wolfgang Brück,et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.
[27] R. Phipps,et al. Prostaglandins as modulators of immunity. , 2002, Trends in immunology.
[28] M. Monestier,et al. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. , 2001, Cellular immunology.
[29] S. Goerdt,et al. Alternatively Activated Antigen-Presenting Cells: Molecular Repertoire, Immune Regulation, and Healing , 2001, Skin Pharmacology and Physiology.
[30] Soken Tsuchiya,et al. The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages1 , 2001, The Journal of Immunology.
[31] C. Lucchinetti,et al. Multiple Sclerosis: Current Pathophysiological Concepts , 2001, Laboratory Investigation.
[32] B. Hinz,et al. Prostaglandin E2 Upregulates Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages , 2000 .
[33] Burkhard Becher,et al. Brain‐immune connection: Immuno‐regulatory properties of CNS‐resident cells , 2000, Glia.
[34] B. Hinz,et al. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. , 2000, Biochemical and biophysical research communications.
[35] Constantin E. Orfanos,et al. Alternative versus Classical Activation of Macrophages , 2000, Pathobiology.
[36] D. Remick,et al. Endotoxin, sepsis, and the primrose path. , 1999, Shock.
[37] H. Cryer,et al. Macrophage TNF mRNA expression induced by LPS is regulated by sphingomyelin metabolites. , 1999, Shock.
[38] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[39] P. Kalinski,et al. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. , 1997, Advances in experimental medicine and biology.
[40] L. Laan,et al. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide , 1996, Journal of Neuroimmunology.
[41] J Newcombe,et al. Microglia‐derived macrophages in early multiple sclerosis plaques , 1996, Neuropathology and applied neurobiology.
[42] E Claassen,et al. Detection of human cytokines in situ using antibody and probe based methods. , 1995, Journal of immunological methods.
[43] C. Raine,et al. Multiple sclerosis: immune system molecule expression in the central nervous system. , 1994, Journal of neuropathology and experimental neurology.
[44] J. Newcombe,et al. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis , 1994, Neuropathology and applied neurobiology.
[45] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[46] W. Norton,et al. MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION 1 , 1973, Journal of neurochemistry.
[47] H. Woelk,et al. Lipid and fatty acid composition of myelin purified from normal and MS brains. , 1973, European neurology.
[48] R. Terry,et al. THE PREPARATION AND SOME PROPERTIES OF PURIFIED MYELIN FROM THE CENTRAL NERVOUS SYSTEM * , 1964, Journal of neurochemistry.